PMID- 37853295 OWN - NLM STAT- MEDLINE DCOM- 20240320 LR - 20240320 IS - 1432-5233 (Electronic) IS - 0940-5429 (Linking) VI - 61 IP - 3 DP - 2024 Mar TI - Higher circulating levels of non-esterified fatty acids are associated with faster kidney function decline in post-menopausal women with type 2 diabetes: a pilot prospective study. PG - 281-288 LID - 10.1007/s00592-023-02198-6 [doi] AB - AIMS: Currently, there is little and inconsistent evidence regarding the possible adverse effects of circulating levels of non-esterified fatty acids (NEFA) on kidney function decline in patients with type 2 diabetes mellitus (T2DM). METHODS: We followed for a median of 4.6 years 85 post-menopausal women with non-insulin-treated T2DM and preserved kidney function at baseline. Serum NEFA concentrations were measured using an enzymatic colorimetric method. Glomerular filtration rate (eGFR) was estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. RESULTS: Enrolled patients had a baseline mean eGFR(CKD-EPI) of 83 +/- 12 mL/min/1.73 m(2) and a median serum NEFA concentration of 662 uEq/L (interquartile range 524-842 uEq/L). During the follow-up period, 13 patients developed kidney function decline at follow-up (defined as an eGFR(CKD-EPI) decline >/= 30% from baseline). In Cox proportional hazards regression analyses, higher serum NEFA levels were significantly associated with an increased risk of developing kidney function decline (adjusted-hazard ratio 3.67, 95% CI 1.64-8.22, p < 0.001; for each 1-SD increment, i.e., 262 uEq/L), even after adjustment for waist circumference, hemoglobin A1c, C-reactive protein, HOMA-estimated insulin resistance, hypertension, dyslipidemia, microalbuminuria, baseline eGFR(CKD-EPI), as well as temporal changes in HbA1c levels or the use of renin-angiotensin system inhibitors over the follow-up. CONCLUSIONS: The findings of this exploratory prospective study show that in post-menopausal women with T2DM and preserved kidney function at baseline, higher circulating levels of NEFA were strongly associated with a faster kidney function decline, even after adjustment for established renal risk factors and potential confounders. CI - (c) 2023. Springer-Verlag Italia S.r.l., part of Springer Nature. FAU - Mantovani, Alessandro AU - Mantovani A AUID- ORCID: 0000-0002-7271-6329 AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. alessandro.mantovani@univr.it. FAU - Csermely, Alessandro AU - Csermely A AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. FAU - Cappelli, Davide AU - Cappelli D AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. FAU - Taverna, Antonio AU - Taverna A AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. FAU - Sani, Elena AU - Sani E AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. FAU - Shtembari, Emigela AU - Shtembari E AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. FAU - Pagani, Micol AU - Pagani M AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. FAU - Targher, Giovanni AU - Targher G AD - Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126, Verona, Italy. AD - IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy. LA - eng PT - Journal Article DEP - 20231018 PL - Germany TA - Acta Diabetol JT - Acta diabetologica JID - 9200299 RN - 0 (Fatty Acids, Nonesterified) SB - IM MH - Humans MH - Female MH - *Diabetes Mellitus, Type 2/epidemiology MH - Prospective Studies MH - Postmenopause MH - Fatty Acids, Nonesterified MH - Kidney MH - Risk Factors MH - *Renal Insufficiency, Chronic/epidemiology MH - Glomerular Filtration Rate OTO - NOTNLM OT - CKD OT - Chronic kidney disease OT - Kidney dysfunction OT - NEFA OT - Non-esterified fatty acids OT - Type 2 diabetes EDAT- 2023/10/19 00:43 MHDA- 2024/03/20 06:46 CRDT- 2023/10/18 23:45 PHST- 2023/05/29 00:00 [received] PHST- 2023/10/04 00:00 [accepted] PHST- 2024/03/20 06:46 [medline] PHST- 2023/10/19 00:43 [pubmed] PHST- 2023/10/18 23:45 [entrez] AID - 10.1007/s00592-023-02198-6 [pii] AID - 10.1007/s00592-023-02198-6 [doi] PST - ppublish SO - Acta Diabetol. 2024 Mar;61(3):281-288. doi: 10.1007/s00592-023-02198-6. Epub 2023 Oct 18.